(Q52839364)

8 May 2018

review article

1 reference

title

Gut microbiome and liver diseases. (English)

1 reference

8 May 2018

0 references

2

1 reference

8 May 2018

author name string

Herbert Tilg

series ordinal

1

1 reference

8 May 2018

Emeran A Mayer

series ordinal

3

1 reference

8 May 2018

language of work or name

English

0 references

publication date

8 October 2016

1 reference

8 May 2018

published in

Gut

1 reference

8 May 2018

volume

65

1 reference

8 May 2018

issue

12

1 reference

8 May 2018

page(s)

2035-2044

1 reference

8 May 2018

Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Early life: gut microbiota and immune development in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Talking microbes: When gut bacteria interact with diet and host organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Stability of gut enterotypes in Korean monozygotic twins and their association with biomarkers and diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Genetic and environmental control of host-gut microbiota interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Personalized Nutrition by Prediction of Glycemic Responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut microbiota and obesity: lessons from the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Human intestinal metagenomics: state of the art and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

An integrated catalog of reference genes in the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Human genetics shape the gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Nonalcoholic fatty liver disease and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut Microbiota of Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Human gut microbes impact host serum metabolome and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Colonic microbiome is altered in alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

The features of mucosa-associated microbiota in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Oral ampicillin inhibits liver regeneration by breaking hepatic innate immune tolerance normally maintained by gut commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Reparative inflammation takes charge of tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Characterization of fecal microbial communities in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Altered profile of human gut microbiome is associated with cirrhosis and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Alterations of the human gut microbiome in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut/brain axis and the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

The interplay between the intestinal microbiota and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

How gut microbes talk to organs: The role of endocrine and nervous routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Towards a systems view of IBS

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut microbes and the brain: paradigm shift in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

The liver-brain axis in liver failure: neuroinflammation and encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut microbiota: its role in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut ammonia production and its modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2016-312729

10.1136/GUTJNL-2016-312729

21 January 2018

Identifiers

DOI

1 reference

8 May 2018

PubMed ID

27802157

1 reference

8 May 2018